Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer

Pancreatic cancer is one of the cancers with very poor prognosis; there is an urgent need to identify novel biomarkers to improve its clinical outcomes. Circulating tumor DNA (ctDNA) from liquid biopsy has arisen as a promising biomarker for cancer detection and surveillance. However, it is known th...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Kazunori, Nakamura, Toru, Kimura, Yasutoshi, Motoya, Masayo, Kojima, Shigeyuki, Kuraya, Tomotaka, Murakami, Takeshi, Kaneko, Tsukasa, Shinohara, Yoshihito, Kitayama, Yosuke, Fukuda, Keito, Hatanaka, Kanako C., Mitsuhashi, Tomoko, Pittella-Silva, Fabio, Yamaguchi, Toshikazu, Hirano, Satoshi, Nakamura, Yusuke, Low, Siew-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570468/
https://www.ncbi.nlm.nih.gov/pubmed/36232820
http://dx.doi.org/10.3390/ijms231911521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570468/
https://www.ncbi.nlm.nih.gov/pubmed/36232820
http://dx.doi.org/10.3390/ijms231911521

Ejemplares similares